The Latest Breaking News from FedEx

Goff threw for the most yards and the most TDs in Week 4 and earned the honor in fan voting

As quickly as the S&P 500 (SPY) fell in September it has bounced as quickly to start October. Yet with inflation still raging, and the Fed likely to keep raising rates that also harms the economy...it becomes hard to get long term bullish at this time. So let’s discuss what…

Seattle Seahawks QB Geno Smith and RB Rashaad Penny have been nominated for the FedEx Air and Ground Players of Week 4. Vote here!

Goff threw for the most yards and most TDs of any QB in Week 4

The shipping industry will likely get a boost in the third quarter. The continued surge in online shopping is expected to be one of the key growth drivers for the industry. While prominent industry participant FedEx doesn’t look well positioned to capitalize on the industry tailwinds, one could invest in…

Despite widespread macro headwinds, lucrative federal investments in the U.S. transportation infrastructure are expected to bode well for the freight and logistics industry, which possesses a significantly positive outlook. FedEx (FDX) and United Parcel Service (UPS) are slated to be primary beneficiaries. But which of these stocks is the better…

Someone with a lot of money to spend has taken a bearish stance on FedEx (NYSE:FDX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

PITTSBURGH — The ball landed with a thud when it struck the FedEx sign in right-center field. For Jack Suwinski, it must have felt strange to hit something to that part of PNC Park and have it actually stay in play. Seems all Suwinski does these days at home is…

FedEx pilots protest a lack of a new pilot contract with the peak shipping season is just weeks away.

It's been a rough couple of weeks on the stock market, ending recently with a warning from FedEX about a downturn in the global economy that sent shares tumbling.

Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day extension to March 13, 2023 to regain compliance.